Cancidas and Fungaemia - a phase IV clinical study of FDA data

Summary:

Fungaemia is reported as a side effect among people who take Cancidas (caspofungin acetate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Ciclosporin, and have Fungal infection.

The phase IV clinical study analyzes which people have Fungaemia when taking Cancidas. It is created by eHealthMe based on reports of 4,868 people who have side effects when taking Cancidas from the FDA, and is updated regularly.

What is Cancidas?

Cancidas has active ingredients of caspofungin acetate. eHealthMe is studying from 4,879 Cancidas users. Check the latest studies of Cancidas.

What is Fungaemia?

Fungaemia (fungi circulate in the blood) is found to be associated with 271 drugs and 381 conditions by eHealthMe. Check the latest studies of Fungaemia.

On Jul, 16, 2026

4,868 people reported to have side effects when taking Cancidas.
Among them, 34 people (0.7%) have Fungaemia.

Among these 34 people:

How long have people been on Cancidas when they have Fungaemia? *

What is the gender of people who have Fungaemia when taking Cancidas? *

female: 30.3 %
male: 69.7 %

What is the age of people who have Fungaemia when taking Cancidas? *

What are other drugs people take besides Cancidas? *

What are other side effects people have besides Fungaemia? *

Drug Ineffective: 14 people, 41.18%
Fungal Infection: 7 people, 20.59%
Drug Resistance (reduction in effectiveness of a drug): 7 people, 20.59%
Death: 5 people, 14.71%
Multi-Organ Failure (multisystem organ failure): 5 people, 14.71%
Candidiasis (candidiasis or thrush is a fungal infection): 4 people, 11.76%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 11.76%
Localised Infection (infection at the single location): 4 people, 11.76%
Fever: 3 people, 8.82%
Fungal Skin Infection: 3 people, 8.82%

What are the existing conditions these people have? *

Fungal Infection: 6 people, 17.65%
Fungal Skin Infection: 3 people, 8.82%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 8.82%
Immunodeficiency Disorders: 2 people, 5.88%
Candidiasis (candidiasis or thrush is a fungal infection): 2 people, 5.88%
Torulopsis Infection (severe urinary tract infection caused by torulopsis glabrata): 1 person, 2.94%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 2.94%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 2.94%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 2.94%
Encephalitis Cytomegalovirus (inflammation of the brain due to cytomegalovirus): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Cancidas and have Fungaemia?

- Check whether Fungaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cancidas:

Cancidas (4,879 reports)

Fungaemia treatments and more:

Fungaemia (2,305 reports)

Browse all side effects of Cancidas:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fungaemia:

Fungaemia (271 drugs)

Browse all the conditions that are associated with Fungaemia:

Fungaemia (381 conditions)

Related publications that referenced our studies

Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .
Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on caspofungin acetate (the active ingredients of Cancidas) and Cancidas (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.